Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart: Comparison with Amiodarone

Circulation

Volumn 100, Issue 22, 1999, Pages 2276-2281

  Sun, Wei ^a   Sarma, Jonnalagedda S M ^a   Singh, Bramah N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Amiodarone; Dronedarone; Drugs; Electrophysiology; Potentials

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BENZOFURAN DERIVATIVE; DRONEDARONE; THYROID HORMONE; THYROXINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT;

EID: 0032749002     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.22.2276     Document Type: Article

References (32)

1. Singh BN. Expanding indications for the use of class III agents in patients at high risk for sudden death. J Cardiovasc Electrophysiol. 1995;6:887-900.
2. Singh BN, Vaughan Williams EM. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol. 1970;39:657-667.
3. Haworth RA, Goknur AB, Berkoff HA. Inhibition of ATP-sensitive potassium channels of adult rat heart cells by antiarrhythmic drugs. Circ Res. 1989;65:1157-1160.
4. Baiser JR, Bennett PB, Hondeghem LM, Roden DM. Suppression of time-dependent outward current in guinea pig ventricular myocytes: Actions of quinidine and amiodarone. Circ Res. 1991;69:519-529.
5. Singh BN, Vaughan Williams EM. Effects of altering potassium concentration on the action of lidocaine and diphenylhydantoin on rabbit atrial and ventricular muscle. Circ Res. 1971;29:286-295.
6. Singh BN, Hauswirth O. Comparative mechanisms of action of antiarrhythmic drugs. Am Heart J. 1974;87:367-382.
7. Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol. 1997;30:791-798.
8. Mason JW. Amiodarone. N Engl J Med. 1987;316:455-466.
9. Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation. 1993;87:1435-1441.
10. Freedberg AS, Papp GJ, Vaughan Williams EM. The effects of altered thyroid state on atrial intracellular potentials. J Physiol (Lond). 1970;207:357-369.
11. Latham KR, Seletti DF, Goldstein RE. Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors. J Am Coll Cardiol. 1987;9:872-876.
12. Norman MF, Lavin T. Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells. J Clin Invest. 1989;83:306-313.
13. Hensley CB, Bersohn MM, Sarma JSM, Singh BN, McDonough AA. Amiodarone decreases Na, K-ATPase alpha2 and beta2 expression specifically in cardiac ventricle. J Mol Cell Cardiol. 1994;26:417-424.
14. Manning AS, Bruyninckx C, Ramboux J, Chatelain P. SR33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. J Cardiovasc Pharmacol. 1995;26:453-461.
15. Manning AS, Thisse V, Hodeige D, Richard J, Heyndrickx JP, Chatelain P. SR33589, a new amiodarone-like antiarrhythmic agent: electrophysiological effects in anesthetized dogs. J Cardiovasc Pharmacol. 1995;25:252-261.
16. Takanaka C, Sarma JSM, Singh BN. Electrophysiologic effects of ambasilidine (LU-47110), a novel class III antiarrhythmic agent, on the properties of isolated rabbit and canine cardiac muscles. J Cardiovasc Pharmacol. 1992;19:290-298.
17. Kodama I, Kamiya K, Toyama J. Cellular electropharmacology of amiodarone. Cardiovasc Res. 1997;35:13-29.
18. Hondeghem LM, Snyder DJ. Class III antiarrhythmic agents have a lot of potential but a long way to go: reduced effectiveness and danger of reverse use dependence. Circulation. 1990;81:686-690.
19. + current: differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol. 1990;96:195-215.
20. Hohnloser S, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects: a review with special reference to torsade de pointes tachycardia. Ann Intern Med. 1994;121:529-535.
21. Anderson KP, Walker R, Dustman T, Lux RL, Ershler PR, Kates RE, Urie PM. Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo. Circulation. 1989;79:948-958.
22. Sager PT, Uppal P, Follmer CT, Antimisiaris M, Pruitt C, Singh BN. Frequency-dependent electrophysiologic effects of amiodarone in humans. Circulation. 1993;88:1063-1072.
23. Epstein LM, Scheinman MM, Chin MC, Katzung BG. The use-dependent effects of acute and chronic amiodarone administration on His-Purkinje conduction and the interaction of beta-adrenergic stimulation. J Cardiovasc Electrophysiol. 1987;2:156-167.
24. Cascio WE, Woelfel A, Knisley SB, Buchanan JW Jr, Foster JR, Gettes LS. Use dependence of amiodarone during the sinus tachycardia of exercise in coronary artery disease. Am J Cardiol. 1988;61:1042-1045.
25. Polster P, Broekhuysen J. The adrenergic antagonism of amiodarone. Biochem Pharmacol. 1976;25:131-134.
26. Ikeda N, Nademanee K, Kannan R, Singh BN. Electrophysiologic effects of amiodarone: experimental and clinical observation relative to serum and tissue drug concentrations. Am Heart J. 1984;108:890-898.
27. Chatelain P, Meysmans L, Matteazzi JR, Beaufort P, Clinet M. Interaction of the antiarrhythmic agents SR33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heart. Br J Pharmacol. 1995;116:1949-1956.
28. Hershman JM, Nademanee K, Sugawara M, Pekary AE, Ross R, Singh BN, DiStefano JJ III. Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone. Acta Endocrinol (Cupenh). 1986;111:193-199.
29. Singh BN, Venkatesh N, Nademanee K, Josephson MA, Kannan R. The historical development, cellular electrophysiology and pharmacology of amiodarone. Prog Cardiovasc Dis. 1989;31:249-280.
30. van Beeren HC, Bakker O., Wiersinga WM. Structure-function relationship of inhibition of the 3,5,3′-triidothyronine binding to the alphal- and betal-thyroid hormone receptor by amiodarone analogs. Endocrinology. 1996;137:2807-2814.
31. Singh BN, Jewitt DE, Downey JM, Kirk ES, Sonnenblick EH. Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials. Clin Exp Pharmacol Physiol. 1976;3:427-442.
32. Vaughan Williams EM, Polster P. The effect of cardiac muscle of two drugs, related to amiodarone, L8040 and L8462. Eur J Pharmacol. 1974;25:241-247.